Bayer Study Director

Trials

Studies that name Bayer Study Director as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:54 UTC. Showing 200 of 1179. Open this list on ClinicalTrials.gov

• Ph1
  NCT04908436 · A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

  Bayer · completed · Worsening Chronic Heart Failure, Chronic Kidney Disease · study director
• Ph1
  NCT04881994 · A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

  Bayer · completed · Worsening Chronic Heart Failure, Diabetic Nephropathy · study director
• Ph1
  NCT04722562 · A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Liver Disease and in Age-, Weight- and Gender-matched Healthy Participants

  Bayer · completed · Heart Failure · study director
• Ph1
  NCT04722484 · A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Kidney Disease and in Age-, Weight- and Gender-matched Healthy Participants

  Bayer · completed · Heart Failure · study director
• Ph3
  NCT04534452 · Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study

  Bayer · completed · Nasal Congestion Due to Allergic Rhinitis · study director
• Ph3
  NCT04534491 · Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.

  Bayer · completed · Overactive Bladder · study director
• Ph4
  NCT04534465 · Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.

  Bayer · completed · Constipation · study director
• Ph3
  NCT04531813 · Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)

  Bayer · completed · Hypersensitivity · study director
• Ph3
  NCT04532164 · Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy Participants

  Bayer · completed · Dermatitis, Photoallergic · study director
• Ph3
  NCT04531540 · Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)

  Bayer · completed · Hypersensitivity · study director
• Ph3
  NCT04531527 · Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects

  Bayer · completed · Dermatitis, Phototoxic · study director
• Ph2
  NCT04507061 · Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.

  Bayer · completed · Chronic Kidney Disease · study director
• N/A
  NCT04462939 · Study to Learn About the Effect of Elevit (a Food Supplement Containing Several Vitamins, Minerals, Lutein and DHA) on the Nutrient Content in the Breast Milk and Blood of Women During Breastfeeding Period and on Babies' Physical Growth Parameters

  Bayer · completed · Healthy Lactating Mother · study director
• N/A
  NCT04438928 · Clinical Study on the Effect of Elevit Pregnancy 2nd & 3rd Trimester (Multi-micronutrients & DHA Supplement) on the Nutritional Status of Pregnant Women During Second and Third Trimester

  Bayer · completed · Healthy Pregnant Women · study director
• N/A
  NCT04383041 · Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool

  Bayer · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT04366622 · Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and Weight

  Bayer · completed · Clinical Pharmacology · study director
• Ph1
  NCT04364464 · Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

  Bayer · completed · Clinical Pharmacology · study director
• Ph1
  NCT04267939 · ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

  Bayer · terminated · Advanced Solid Tumors (Excluding Prostate Cancer), Ovarian Cancer · study director
• Ph1
  NCT03929861 · Bioequivalence Trial to Prove Equal Blood Concentrations of Two Different Fluconazole Formulations

  Bayer · completed · Pharmacology, Clinical · study director
• N/A
  NCT03799016 · An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan

  Bayer · completed · Venous Thromboembolism · study director
• Ph1
  NCT03754660 · This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

  Bayer · completed · Hypertension, Pulmonary · study director
• Ph1
  NCT03704519 · Imaging Study to Compare Effects of Darolutamide and Enzalutamide With Respect to Placebo on the Blood Flow in the Brain in Healthy Male Volunteers.

  Bayer · completed · Cerebrovascular Circulation · study director
• Ph1
  NCT03666273 · Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

  Bayer · completed · Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma · study director
• Ph1
  NCT03596372 · Study of BAY1834942 in Patients With Solid Tumors

  Bayer · completed · Advanced CEACAM6-expressing Solid Tumors · study director
• N/A
  NCT03577977 · Betaferon Use in Children and Adolescents With Multiple Sclerosis

  Bayer · completed · Multiple Sclerosis · study director
• Ph2
  NCT03573336 · Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis

  Bayer · terminated · Endometriosis · study director
• Ph2
  NCT03562624 · A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components

  Bayer · completed · Contraception · study director
• Ph1
  NCT03507452 · First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

  Bayer · completed · Advanced Recurrent Malignant Pleural Epithelioid Mesothelioma, Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma, Advanced Recurrent Serous Ovarian Cancer · study director
• Ph1
  NCT03498430 · Copanlisib Chinese PK Study

  Bayer · completed · Lymphoma, Non-Hodgkin · study director
• Ph1
  NCT03493269 · A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis

  Bayer · completed · Healthy Volunteers, Psoriasis · study director
• Ph1
  NCT03484585 · Rogaratinib (BAY1163877) Human Mass Balance Study

  Bayer · completed · Clinical Trial, Phase I, Pharmacokinetics · study director
• N/A
  NCT03462446 · Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

  Bayer · completed · Atrial Fibrillation · study director
• Ph1
  NCT03424135 · A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects Under Fed Conditions

  Bayer · completed · Clinical Pharmacology · study director
• N/A
  NCT03411941 · Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)

  Bayer · completed · Macular Degeneration · study director
• N/A
  NCT03410706 · Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in China

  Bayer · completed · Pulmonary Embolism · study director
• Ph2/Ph3
  NCT03410693 · Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

  Bayer · completed · Carcinoma, Transitional Cell · study director
• N/A
  NCT03408093 · Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

  Bayer · completed · Multiple Sclerosis · study director
• Ph1
  NCT03402438 · Renal Impairment Study

  Bayer · completed · Clinical Trial, Phase I · study director
• Ph3
  NCT03400956 · Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

  Bayer · terminated · Uterine Fibroids · study director
• Ph3
  NCT03400943 · Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

  Bayer · terminated · Uterine Fibroids · study director
• Ph1
  NCT03399526 · 1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

  Bayer · completed · Psoriasis · study director
• Ph1
  NCT03396250 · A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects

  Bayer · completed · Pain · study director
• N/A
  NCT03382587 · Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients

  Bayer · completed · Wet Age-related Macular Degeneration · study director
• Ph2
  NCT03373422 · A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best

  Bayer · terminated · Endometriosis · study director
• Ph1
  NCT03350295 · Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg

  Bayer · completed · Chagas Disease · study director
• Ph3
  NCT03349684 · Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients

  Bayer · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03342859 · Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned

  Bayer · terminated · Leiomyoma · study director
• Ph1/Ph2
  NCT03310645 · Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients

  Bayer · completed · Cough · study director
• Ph2
  NCT03276143 · FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty

  Bayer · completed · Knee Arthroplasty, Total · study director
• Ph1
  NCT03255512 · Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients

  Bayer · completed · Coronary Artery Disease · study director
• Ph1
  NCT03252002 · Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects

  Bayer · completed · Healthy Volunteer · study director
• Ph1
  NCT03244462 · Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate

  Bayer · completed · Inflammation · study director
• N/A
  NCT03242278 · Real-world Dosing Patterns of Rivaroxaban in the United States

  Bayer · completed · Atrial Fibrillation · study director
• Ph3
  NCT03240523 · A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

  Bayer · terminated · Uterine Fibroids · study director
• Ph1
  NCT03237416 · Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers

  Bayer · completed · Prostatic Neoplasms · study director
• Ph1
  NCT03235076 · Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects

  Bayer · completed · Renal Impairment · study director
• Ph1
  NCT03210246 · Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)

  Bayer · completed · Clinical Trial ,Phase I · study director
• N/A
  NCT03194633 · Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study

  Bayer · completed · Hypertension · study director
• Ph3
  NCT03194646 · Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

  Bayer · terminated · Uterine Fibroids · study director
• Ph1
  NCT03188965 · First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

  Bayer · completed · Advanced Solid Tumor, Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma · study director
• Ph1
  NCT03172884 · Study of Copanlisib in Hepatic or Renal Impairment

  Bayer · completed · Hepatic Insufficiency, Renal Insufficiency · study director
• Ph1
  NCT03145038 · Relative Bioavailability and Food Effect Study With Vericiguat to Characterize the Pediatric Formulation in Adult Healthy Subjects

  Bayer · completed · Pharmacokinetics · study director
• Ph1
  NCT03136666 · Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.

  Bayer · completed · Clinical Pharmacology · study director
• N/A
  NCT03134573 · Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

  Bayer · completed · Multiple Sclerosis · study director
• Ph2
  NCT03128320 · The Effects of BAY1193397 on Skin Capillary Blood Flow and Transcutaneous Oxygen Pressure

  Bayer · completed · Diabetic Foot · study director
• N/A
  NCT03127722 · Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization

  Bayer · completed · Contraception · study director
• N/A
  NCT03126747 · Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea

  Bayer · completed · Endometriosis and Dysmenorrhea · study director
• Ph1
  NCT03119077 · Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116

  Bayer · terminated · Polycystic Ovary Syndrome · study director
• Ph2
  NCT03098979 · A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

  Bayer · completed · Heart Failure · study director
• Ph1
  NCT03092999 · Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)

  Bayer · completed · Leiomyoma · study director
• Ph3
  NCT03074045 · LCS16 vs. COC User Satisfaction and Tolerability Study

  Bayer · completed · Contraception · study director
• Ph1
  NCT03074058 · Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

  Bayer · completed · Clinical Pharmacology · study director
• Ph1
  NCT03056703 · Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets

  Bayer · completed · Pain · study director
• Ph1
  NCT03054402 · First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845

  Bayer · completed · Pelvic Inflammatory Disease · study director
• Ph1
  NCT03048110 · Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction

  Bayer · completed · Biological Availability · study director
• N/A
  NCT03002922 · Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)

  Bayer · completed · Sunscreening Agents · study director
• Ph2
  NCT02992288 · A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction

  Bayer · completed · Heart Failure · study director
• N/A
  NCT02991131 · Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study

  Bayer · terminated · Skin Disease, Infectious · study director
• Ph3
  NCT02985541 · Mirena Extension Trial

  Bayer · completed · Contraception · study director
• Ph2
  NCT02976467 · A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction

  Bayer · completed · Myocardial Infarction · study director
• Ph1
  NCT02975440 · Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan

  Bayer · completed · Endometriosis · study director
• N/A
  NCT02975453 · Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban

  Bayer · completed · Atrial Fibrillation · study director
• N/A
  NCT02963675 · Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden

  Bayer · completed · Prostatic Neoplasms · study director
• N/A
  NCT02962856 · Human Phototoxicity Test (823/2016)

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02962869 · Human Photoallergy Test (824/2016)

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02960880 · Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

  Bayer · completed · Atrial Fibrillation · study director
• Ph1
  NCT02956109 · Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers

  Bayer · completed · Pharmacokinetics · study director
• N/A
  NCT02941783 · Drug Use Investigation of Kovaltry in Hemophilia A Patients

  Bayer · completed · Hemophilia A · study director
• Ph1
  NCT02940002 · BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

  Bayer · completed · Psoriasis · study director
• Ph1
  NCT02936492 · BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

  Bayer · terminated · Psoriasis · study director
• N/A
  NCT02924311 · Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema

  Bayer · completed · Diabetic Retinopathy · study director
• N/A
  NCT02903888 · A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years

  Bayer · completed · Intrauterine Devices, Medicated · study director
• N/A
  NCT02899104 · Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )

  Bayer · completed · Prostatic Neoplasms, Castration-Resistant · study director
• N/A
  NCT02900404 · Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm

  Bayer · withdrawn · Atrial Fibrillation, Venous Thromboembolism, Pulmonary Embolism · study director
• Ph1
  NCT02894385 · Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

  Bayer · completed · Pharmacokinetics, Hepatic Insufficiency, Renal Insufficiency · study director
• Ph4
  NCT02891850 · Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy

  Bayer · completed · Pulmonary Arterial Hypertension · study director
• N/A
  NCT02885805 · Sun Protection Factor (SPF) Efficacy Assay

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02877511 · Supervised Outdoor-Use Test For Sunscreen Products in Adults

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02876718 · Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study

  Bayer · completed · Atrial Fibrillation · study director
• N/A
  NCT02875106 · A Digital Non-interventional Atrial Fibrillation (AF) Screening Study With Commercial Pulse Detection Systems

  Bayer · completed · Atrial Fibrillation · study director
• N/A
  NCT02872246 · Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) - Assay

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02872220 · To Test for Photo Allergy Reaction of Sunscreens

  Bayer · completed · Photoallergy · study director
• N/A
  NCT02872194 · Evaluation of the Stinging Potential of Products in Human Eyes

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02872233 · Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02872207 · Evaluation of the Stinging Potential in Human Eyes

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02869113 · Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02864758 · Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

  Bayer · completed · Atrial Fibrillation · study director
• N/A
  NCT02857478 · Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02857738 · Sun Protection Factor (SPF) - Static and Water Resistant Assay

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02857725 · Sun Protection Factor (SPF) Assay

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02854137 · Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02850263 · A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema

  Bayer · completed · Macular Edema · study director
• N/A
  NCT02842268 · Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02840903 · A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting

  Bayer · completed · Angiography, Multidetector Computed Tomography · study director
• N/A
  NCT02830477 · Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

  Bayer · completed · Hemophilia A, Congenital · study director
• N/A
  NCT02831478 · Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02825030 · Sun Protection Factor Assay (SPF Assay 18676)

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02825017 · Sun Protection Factor Assay (SPF Assay 18677)

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02826252 · Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

  Bayer · completed · Hypertension, Pulmonary · study director
• N/A
  NCT02825160 · Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

  Bayer · completed · Hypertension, Pulmonary · study director
• Ph1
  NCT02824042 · Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

  Bayer · completed · Medical Oncology · study director
• N/A
  NCT02823496 · 18349-Human Photoallergy Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02823509 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02823483 · 18348-Human Phototoxicity Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02822313 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02822274 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02822300 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02822248 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02822261 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02821247 · Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece

  Bayer · completed · Choroidal Neovascularization, Macular Degeneration · study director
• Ph3
  NCT02818998 · Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)

  Bayer · completed · Macular Edema · study director
• Ph1
  NCT02817100 · First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080

  Bayer · completed · Clinical Trials, Phase I as Topic · study director
• N/A
  NCT02811692 · Study for Collection of Aflibercept Data in Routine Practice

  Bayer · completed · Eye Diseases · study director
• N/A
  NCT02803437 · Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

  Bayer · completed · Prostatic Neoplasms, Castration-Resistant · study director
• N/A
  NCT02803047 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02803034 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02803099 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02802930 · Test the Phototoxicity of Sunscreen Products

  Bayer · completed · Sunscreen Agents · study director
• N/A
  NCT02802917 · To Evaluate Eye Installation-Tear Free

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02803320 · To Assess the Safety of a Sunscreen Product

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02803021 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02801929 · 18670 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02803008 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02803060 · Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• Ph4
  NCT02800642 · Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

  Bayer · completed · Central Retinal Vein Occlusion · study director
• Ph3
  NCT02799602 · Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer

  Bayer · completed · Metastatic Hormone-sensitive Prostate Cancer · study director
• N/A
  NCT02788162 · 18616 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02788409 · Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US

  Bayer · completed · Prostatic Neoplasms · study director
• N/A
  NCT02784717 · Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

  Bayer · completed · Stroke · study director
• N/A
  NCT02779270 · Test the Outdoor Usage for Sunscreen Products in Female Adults

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02779829 · 18432-Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02779842 · Sun Protection Factor - Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02776852 · 18519 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02776501 · 18572 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02774252 · 18475 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02766283 · Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure

  Bayer · completed · Hypothyroidism · study director
• N/A
  NCT02760563 · 18611 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02760576 · 18612 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agents · study director
• Ph4
  NCT02759419 · A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

  Bayer · completed · Hypertension, Pulmonary · study director
• N/A
  NCT02756988 · 18615 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02757014 · 18613 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02754102 · Human Phototoxicity Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02751515 · Human Photoallergy Test

  Bayer · completed · Sunscreening Agents · study director
• Ph1
  NCT02751918 · Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer

  Bayer · completed · Ovarian Neoplasms · study director
• N/A
  NCT02751541 · Human Phototoxicity Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02751567 · 18776 - Human Photoallergy Test

  Bayer · withdrawn · Sunscreening Agents · study director
• N/A
  NCT02751463 · 18850 - Human Photoallergy Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02751372 · 18794 - Human Photo Toxicity Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02751489 · Human Phototoxicity Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02750488 · 18793 - Human Photoallergy Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02750449 · Human Photoallergy Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02750475 · Human Phototoxicity Test

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02749396 · EPID Multiple Sclerosis Pregnancy Study

  Bayer · completed · Multiple Sclerosis · study director
• Ph1
  NCT02746081 · Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors

  Bayer · completed · Solid Tumors · study director
• Ph1
  NCT02745743 · Phase I Trial of BAY1251152 for Advanced Blood Cancers

  Bayer · completed · Hematologic Neoplasms · study director
• N/A
  NCT02742623 · A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

  Bayer · completed · Venous Thrombosis and Pulmonary Embolism · study director
• N/A
  NCT02741466 · 18750-Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agents · study director
• N/A
  NCT02739802 · 18751-Sun Protection Factor Assay.

  Bayer · completed · Sunscreening Agents · study director
• Ph4
  NCT02734628 · Pilot Study to Assess Number of Patients for Main Trial

  Bayer · completed · Wound Healing · study director
• N/A
  NCT02729103 · Treatment Patterns in Metastatic Prostate Cancer

  Bayer · completed · Prostatic Neoplasm · study director
• N/A
  NCT02728856 · Evaluation of the Irritation Potential of Products in Human Eyes.

  Bayer · completed · Sunscreening Agents · study director
• Ph2
  NCT02722083 · Exploratory Study for Allergy Relief Onset

  Bayer · terminated · Rhinitis, Allergic · study director
• N/A
  NCT02717351 · 18841- Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02717325 · 18842 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02714166 · Evaluation of the Irritation Potential of Products in Human Eyes

  Bayer · completed · Sunscreening Agents · study director
• Ph4
  NCT02710708 · YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

  Bayer · completed · Contraception · study director
• N/A
  NCT02702908 · Second Primary Cancers in Patients With Castration Resistant Prostate Cancer

  Bayer · completed · Prostatic Neoplasms · study director
• Ph1
  NCT02696642 · Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

  Bayer · completed · Neoplasms · study director
• N/A
  NCT02695303 · 18790 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• N/A
  NCT02690155 · Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

  Bayer · completed · Atrial Fibrillation · study director
• N/A
  NCT02687854 · Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

  Bayer · completed · Atrial Fibrillation · study director
• N/A
  NCT02687867 · Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

  Bayer · completed · Atrial Fibrillation · study director
• N/A
  NCT02682654 · A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and Instability

  Bayer · completed · Joint Instability · study director
• N/A
  NCT02682628 · 18791 - Sun Protection Factor Assay

  Bayer · completed · Sunscreening Agent · study director
• Ph1
  NCT02671097 · Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

  Bayer · completed · Healthy Volunteers, Pharmacokinetics, Drug Interaction · study director
• N/A
  NCT02661438 · Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

  Bayer · completed · Bronchiectasis, Pulmonary Disease, Chronic Obstructive · study director
• N/A
  NCT02656524 · Stivarga Real Life Evidence in Hungary

  Bayer · completed · Colorectal Neoplasms · study director
• N/A
  NCT02652091 · Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction

  Bayer · completed · Multiple Sclerosis, Relapsing-Remitting · study director
• N/A
  NCT02645747 · Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion

  Bayer · completed · Retinal Vein Occlusion · study director
• Ph1
  NCT02639091 · Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

  Bayer · completed · Medical Oncology · study director

Grants

NIH projects from RePORTER, fetched 2026-11-11 17:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.